The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Comparison of HepG2 and HepaRG by Whole-Genome Gene Expression Analysis for the Purpose of Chemical Hazard Identification
Open accessAbstract
Direct comparison of the hepatoma cell lines HepG2 and HepaRG has previously been performed by only evaluating a limited set of genes or proteins. In this study, we examined the whole-genome gene expression of both cell lines before and after exposure to the genotoxic (GTX) carcinogens aflatoxin B1 and benzo[a]pyrene and the nongenotoxic (NGTX) carcinogens cyclosporin A, 17beta-estradiol, and 2,3,7,8-tetrachlorodibenzo-para-dioxin for 12 and 48 h. Before exposure, this analysis revealed an extensive network of genes and pathways, which were regulated differentially for each cell line. The comparison of the basal gene expression between HepG2, HepaRG, primary human hepatocytes (PHH), and liver clearly showed that HepaRG resembles PHH and liver the most. After exposure to the GTX and NGTX carcinogens, for both cell lines, common pathways were found that are important in carcinogenesis, for example, cell cycle regulation and apoptosis. However, also clear differences between exposed HepG2 and HepaRG were observed, and these are related to common metabolic processes, immune response, and transcription processes. Furthermore, HepG2 performs better in discriminating between GTX and NGTX carcinogens. In conclusion, these results have shown that HepaRG is a more suited in vitro liver model for biological interpretations of the effects of exposure to chemicals, whereas HepG2 is a more promising in vitro liver model for classification studies using the toxicogenomics approach. Although, it should be noted that only five carcinogens were used in this study.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Commercial cell lines including HepG2/C3A provide a more stable, easy-to-handle and readily available source of human cells for in vitro studies on liver function and general mechanisms of toxicity [58,59].”
From A liver-on-a-chip platform with bioprinted hepatic spheroids (2016) · cites this paper as [58]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. (1983) · Journal of Immunological Methods · doi:10.1016/0022-1759(83)90303-4 · Cited by 56,104
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
Irizarry, R. A. (2003) · Biostatistics · doi:10.1093/biostatistics/4.2.249 · Cited by 10,603
Diagnosis of multiple cancer types by shrunken centroids of gene expression
Tibshirani, R. J., Hastie, T. J., Narasimhan, B., & Chu, G. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082099299 · Cited by 2,931
Reich, M. M., Liefeld, T., Gould, J., Lerner, J., Tamayo, P., & Mesirov, J. P. (2006) · Nature Genetics · doi:10.1038/ng0506-500 · Cited by 2,053
Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data
Dai, M. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni179 · Cited by 1,807
Cytochrome P450 and Chemical Toxicology
Guengerich, F. P. (2007) · Chemical Research in Toxicology · doi:10.1021/tx700079z · Cited by 1,789
Gelboin, H. V. (1980) · Physiological Reviews · doi:10.1152/physrev.1980.60.4.1107 · Cited by 1,280
Wilkening, S., Stahl, F., & Bader, A. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.8.1035 · Cited by 794
Guillouzo, A., Corlu, A., Aninat, C., Glaise, D., Morel, F., & Guguen‐Guillouzo, C. (2006) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2006.12.003 · Cited by 714
Cytochrome P450-mediated metabolism of estrogens and its regulation in human
Tsuchiya, Y., Nakajima, M., & Yokoi, T. (2005) · Cancer Letters · doi:10.1016/j.canlet.2004.10.007 · Cited by 616
Flagged first, then by citations
Cited by
Sorted by citations
Gerets, H. H. J., Tilmant, K., Gerin, B., Chanteux, H., Depelchin, B. O., Dhalluin, S., & Atienzar, F. A. (2012) · Cell Biology and Toxicology · doi:10.1007/s10565-011-9208-4 · Cited by 698
A liver-on-a-chip platform with bioprinted hepatic spheroids
Bhise, N. S., Manoharan, V., Massa, S., Tamayol, A., Ghaderi, M., Miscuglio, M., Lang, Q., Shrike Zhang, Y., Shin, S. R., Calzone, G., et al. (2016) · Biofabrication · doi:10.1088/1758-5090/8/1/014101 · Cited by 615
The Curious Case of the HepG2 Cell Line: 40 Years of Expertise
Arzumanian, V. A., Kiseleva, O. I., & Poverennaya, E. V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222313135 · Cited by 387
Organotypic liver culture models: meeting current challenges in toxicity testing
LeCluyse, E. L., Witek, R. P., Andersen, M. E., & Powers, M. J. (2012) · Critical Reviews in Toxicology · doi:10.3109/10408444.2012.682115 · Cited by 363
Guo, L., Dial, S., Shi, L., Branham, W., Liu, J., Fang, J.-L., Green, B., Deng, H., Kaput, J., & Ning, B. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.035873 · Cited by 348
Lauschke, V. M., Hendriks, D. F. G., Bell, C. C., Andersson, T. B., & Ingelman-Sundberg, M. (2016) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6b00150 · Cited by 241
Huang, J.-L., Cao, S., Ou, Q., Yang, B., Zheng, S., Tang, J. Y., Chen, J., Hu, Y., Zheng, L., & Wang, Q. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0841-x · Cited by 214
Optimization of the HepaRG cell model for drug metabolism and toxicity studies
Anthérieu, S., Chesné, C., Li, R., Guguen‐Guillouzo, C., & Guillouzo, A. (2012) · Toxicology in Vitro · doi:10.1016/j.tiv.2012.05.008 · Cited by 189
Ma, L.-D., Wang, Y., Wang, J., Wu, J., Meng, X., Hu, P., Mu, X., Liang, Q., & Luo, G. (2018) · Lab on a Chip · doi:10.1039/c8lc00333e · Cited by 168
Comparative cytotoxicity of nanosilver in human liver HepG2 and colon Caco2 cells in culture
Sahu, S. C., Zheng, J., Graham, L., Chen, L., Ihrie, J., Yourick, J. J., & Sprando, R. L. (2014) · Journal of Applied Toxicology · doi:10.1002/jat.2994 · Cited by 162
Thomas, R. S., Black, M. B., Li, L., Healy, E., Chu, T., Bao, W., Andersen, M. E., & Wolfinger, R. D. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfs159 · Cited by 149
In Vitro Models for Non-Alcoholic Fatty Liver Disease: Emerging Platforms and Their Applications
Ramos, M. J., Bandiera, L., Menolascina, F., & Fallowfield, J. A. (2022) · iScience · doi:10.1016/j.isci.2021.103549 · Cited by 127
Garcia‐Canton, C., Minet, E., Anadón, A., & Meredith, C. (2013) · Toxicology in Vitro · doi:10.1016/j.tiv.2013.05.001 · Cited by 118
Zhang, J., Li, H., Zhang, Y., Huang, J., Ren, L., Zhang, C., Zou, Q., & Zhang, Y. (2025) · Briefings in Bioinformatics · doi:10.1093/bib/bbaf533 · Cited by 134
Chopra, M., & Schrenk, D. (2011) · Critical Reviews in Toxicology · doi:10.3109/10408444.2010.524635 · Cited by 114
Proteomics Investigations of Drug-Induced Hepatotoxicity in HepG2 Cells
Summeren, A. V., Renes, J., Bouwman, F. G., Noben, J., van Delft, J. H. M., Kleinjans, J. C. S., & Mariman, E. C. M. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq380 · Cited by 109
Self-citationComparative Gene Expression Profiles Induced by PPARγ and PPARα/γ Agonists in Human Hepatocytes
Rogue, A., Lambert, C. B., Jossé, R., Anthérieu, S., Spire, C., Claude, N., & Guillouzo, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018816 · Cited by 110
Sison-Young, R. L. C., Mitsa, D., Jenkins, R. E., Mottram, D. R., Alexandre, E., Richert, L., Aerts, H., Weaver, R. J., Jones, R. P., Johann, E., et al. (2015) · Toxicological Sciences · doi:10.1093/toxsci/kfv136 · Cited by 99
Comparison of Liver Cell Models Using the Basel Phenotyping Cocktail
Berger, B., Donzelli, M., Maseneni, S., Boess, F., Roth, A. B., Krähenbühl, S., & Haschke, M. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00443 · Cited by 92
Driessen, M., Kienhuis, A. S., Pennings, J. L. A., Pronk, T. E., van den Brandhof, E., Roodbergen, M., Spaink, H. P., van de Water, B., & van der Ven, L. T. M. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1039-z · Cited by 93
A transcriptomics-based in vitro assay for predicting chemical genotoxicity in vivo
Magkoufopoulou, C., Claessen, S. M. H., Tsamou, M., Jennen, D. G. J., Kleinjans, J. C. S., & van Delft, J. H. M. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs182 · Cited by 86
Self-citationRuiz‐Aracama, A., Peijnenburg, A., Kleinjans, J. C. S., Jennen, D. G. J., van Delft, J. H. M., Hellfrisch, C., & Lommen, A. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-251 · Cited by 90
Self-citationGarcia‐Canton, C., Anadón, A., & Meredith, C. (2012) · Toxicology in Vitro · doi:10.1016/j.tiv.2012.06.006 · Cited by 80
van Delft, J. H. M., Gaj, S., Lienhard, M., Albrecht, M. W., Кирпий, А. А., Brauers, K. J. J., Claessen, S. M. H., Lizárraga, D., Lehrach, H., Herwig, R., et al. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfs250 · Cited by 75
Self-citationSagar, S., Esau, L. E., Moosa, B., Khashab, N. M., Bajić, V. B., & Kaur, M. (2014) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/18715206113136660369 · Cited by 74
Experimental liver models: From cell culture techniques to microfluidic organs‐on‐chip
Polidoro, M. A., Ferrari, E., Marzorati, S., Lleò, A., & Rasponi, M. (2021) · Liver International · doi:10.1111/liv.14942 · Cited by 77
Rogue, A., Lambert, C. B., Spire, C., Claude, N., & Guillouzo, A. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.042028 · Cited by 72
Xia, P., Zhang, X., Zhang, H., Wang, P., Tian, M., & Yu, H. (2017) · Environmental Science & Technology · doi:10.1021/acs.est.7b02648 · Cited by 72
Grouping 34 Chemicals Based on Mode of Action Using Connectivity Mapping
Abrew, K. N. D., Kainkaryam, R. M., Shan, Y. K., Overmann, G. J., Settivari, R. S., Wang, X., Xu, J., Adams, R. L., Tiesman, J. P., Carney, E. W., et al. (2016) · Toxicological Sciences · doi:10.1093/toxsci/kfw058 · Cited by 70
Yildirimman, R., Brolén, G., Vilardell, M., Eriksson, G., Synnergren, J., Gmuender, H., Kamburov, A., Ingelman‐Sundberg, M., Castell, J. V., Lahoz, A., et al. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr225 · Cited by 63
Self-citationDere, E., Lee, A. W., Burgoon, L. D., & Zacharewski, T. R. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-193 · Cited by 62
Kyffin, J. A., Sharma, P., Leedale, J., Colley, H. E., Murdoch, C., Mistry, P., & Webb, S. D. (2018) · Toxicology in Vitro · doi:10.1016/j.tiv.2018.01.023 · Cited by 64
Jossé, R., Dumont, J., Fautrel, A., Robin, M., & Guillouzo, A. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.10.019 · Cited by 65
Kammerer, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910214 · Cited by 59
Shi, J., Wang, X., Lyu, L., Jiang, H., & Zhu, H. (2018) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2018.03.003 · Cited by 60
Xenobiotic metabolism in differentiated human bronchial epithelial cells
Boei, J. J. W. A., Vermeulen, S., Klein, B., Hiemstra, P. S., Verhoosel, R. M., Jennen, D. G. J., Lahoz, A., Gmuender, H., & Vrieling, H. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1868-7 · Cited by 58
Self-citationRodrigues, R. M., Kock, J. D., Branson, S., Vinken, M., Meganathan, K., Chaudhari, U., Sachinidis, A., Govaere, O., Roskams, T., Boe, V. D., et al. (2013) · Stem Cells and Development · doi:10.1089/scd.2013.0157 · Cited by 57
Jetten, M. J., Kleinjans, J. C. S., Claessen, S. M. H., Chesné, C., & van Delft, J. H. M. (2013) · Toxicology in Vitro · doi:10.1016/j.tiv.2013.07.010 · Cited by 56
Self-citationA review on ochratoxin A transcriptomic studies
Vettorazzi, A., van Delft, J. H. M., & de Ceráin, A. L. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.05.043 · Cited by 57
Transcriptomic responses generated by hepatocarcinogens in a battery of liver-based in vitro models
Doktorova, T. Y., Yildirimman, R., Vinken, M., Vilardell, M., Vanhaecke, T., Gmuender, H., Bort, R., Brolén, G., Holmgren, G., Li, R., et al. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt054 · Cited by 55
Self-citationMagkoufopoulou, C., Claessen, S. M. H., Jennen, D. G. J., Kleinjans, J. C. S., & van Delft, J. H. M. (2011) · Mutagenesis · doi:10.1093/mutage/ger021 · Cited by 55
Self-citationThyroid hormone induction of human cholesterol 7 alpha-hydroxylase (Cyp7a1) in vitro
Lindemann, J. A. L., Angajala, A., Engler, D. A., Webb, P., & Ayers, S. D. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.02.003 · Cited by 52
Metabolic and phenotypic changes induced by PFAS exposure in two human hepatocyte cell models
Alijagić, A., Sinisalu, L., Duberg, D., Kotlyar, O., Scherbak, N. N., Engwall, M., Orešič, M., & Hyötyläinen, T. (2024) · Environment International · doi:10.1016/j.envint.2024.108820 · Cited by 53
Environmental epitranscriptomics
Çayır, A., Byun, H., & Barrow, T. M. (2020) · Environmental Research · doi:10.1016/j.envres.2020.109885 · Cited by 50
Human hepatocyte systems for in vitro toxicology analysis
Kammerer, S., & Küpper, J. (2018) · Journal of Cellular Biotechnology · doi:10.3233/jcb-179012 · Cited by 50
Epigenetic mechanisms underlying arsenic-associated lung carcinogenesis
Breda, S. G. J. V., Claessen, S. M. H., Lo, K. C., van Herwijnen, M. H. M., Brauers, K. J. J., Lisanti, S., Theunissen, D. H. J., Jennen, D. G. J., Gaj, S., de Kok, T. M. C. M., et al. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1351-2 · Cited by 47
Self-citationDevelopment of novel tools for thein vitroinvestigation of drug-induced liver injury
Jiang, J., Wolters, J. E. J., van Breda, S. G., Kleinjans, J. C. S., & de Kok, T. M. C. M. (2015) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2015.1065814 · Cited by 46
Self-citationSeo, J., Tryndyak, V., Wu, Q., Dreval, K., Pogribny, I. P., Bryant, M., Zhou, T., Robison, T. W., Mei, N., & Guo, X. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02406-9 · Cited by 46
Toxicogenomic responses of human liver HepG2 cells to silver nanoparticles
Sahu, S. C., Zheng, J., Yourick, J. J., Sprando, R. L., & Gao, X. (2015) · Journal of Applied Toxicology · doi:10.1002/jat.3170 · Cited by 45
Jennen, D. G. J., Ruiz‐Aracama, A., Magkoufopoulou, C., Peijnenburg, A., Lommen, A., van Delft, J. H. M., & Kleinjans, J. C. S. (2011) · BMC Systems Biology · doi:10.1186/1752-0509-5-139 · Cited by 47
Self-citationTime series analysis of oxidative stress response patterns in HepG2: A toxicogenomics approach
Deferme, L., Briedé, J. J., Claessen, S. M. H., Jennen, D. G. J., Cavill, R., & Kleinjans, J. C. S. (2013) · Toxicology · doi:10.1016/j.tox.2013.02.001 · Cited by 45
Self-citationMicroRNA Responses to the Genotoxic Carcinogens Aflatoxin B1and Benzo[a]pyrene in Human HepaRG Cells
Marrone, A. K., Tryndyak, V., Beland, F. A., & Pogribny, I. P. (2015) · Toxicological Sciences · doi:10.1093/toxsci/kfv253 · Cited by 44
Effects of usnic acid exposure on human hepatoblastoma HepG2 cells in culture
Sahu, S. C., Amankwa‐Sakyi, M., O'Donnell, M. W., & Sprando, R. L. (2011) · Journal of Applied Toxicology · doi:10.1002/jat.1721 · Cited by 44
Performance of in vitro γH2AX assay in HepG2 cells to predict in vivo genotoxicity
Tsamou, M., Jennen, D. G. J., Claessen, S. M. H., Magkoufopoulou, C., Kleinjans, J. C. S., & van Delft, J. H. M. (2012) · Mutagenesis · doi:10.1093/mutage/ges030 · Cited by 44
Self-citationCharacterisation of a functional rat hepatocyte spheroid model
Kyffin, J. A., Sharma, P., Leedale, J., Colley, H. E., Murdoch, C., Harding, A. L., Mistry, P., & Webb, S. D. (2018) · Toxicology in Vitro · doi:10.1016/j.tiv.2018.12.014 · Cited by 43
Ambolet-Camoit, A., Ottolenghi, C., Leblanc, A. F., Kim, M. J., Letourneur, F., Jacques, S., Cagnard, N., Guguen‐Guillouzo, C., Barouki, R., & Aggerbeck, Μ. (2015) · Biochimie · doi:10.1016/j.biochi.2015.07.003 · Cited by 41
Yousefi, B., Darabi, M., Baradaran, B., Khaniani, M. S., Rahbani, M., Darabi, M., Fayezi, S., Mehdizadeh, A., Saliani, N., & Shaaker, M. (2012) · Europe PMC (PubMed Central) · doi:10.5681/bi.2012.019 · Cited by 40
Jennen, D. G. J., Gaj, S., Giesbertz, P., van Delft, J. H. M., Evelo, C. T., & Kleinjans, J. C. S. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.08.002 · Cited by 41
Self-citationTranscriptional and Epigenetic Consequences of DMSO Treatment on HepaRG Cells
Dubois‐Pot‐Schneider, H., Aninat, C., Kattler, K., Fekir, K., Jarnouen, K., Cérec, V., Glaise, D., Salhab, A., Gasparoni, G., Takashi, K., et al. (2022) · Cells · doi:10.3390/cells11152298 · Cited by 39
Parks, L. G. (2013) · ALTEX · doi:10.14573/altex.2013.3.353 · Cited by 39
Cytostatic and genotoxic effect of temephos in human lymphocytes and HepG2 cells
Benítez-Trinidad, A. B., Herrera‐Moreno, J. F., Vázquez-Estrada, G., Verdín-Betancourt, F. A., Sordo, M., Ostrosky‐Wegman, P., Bernal-Hernández, Y. Y., Medina‐Díaz, I. M., Barrón-Vivanco, B. S., Robledo-Marenco, M. L., et al. (2015) · Toxicology in Vitro · doi:10.1016/j.tiv.2015.02.008 · Cited by 40
Sahu, S. C., Roy, S. K., Zheng, J., Yourick, J. J., & Sprando, R. L. (2014) · Journal of Applied Toxicology · doi:10.1002/jat.3028 · Cited by 37
Radford, R., Slattery, C., Jennings, P., Blacque, O. E., Pfaller, W., Gmuender, H., van Delft, J. H. M., Ryan, M. P., & McMorrow, T. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00427.2011 · Cited by 36
Guo, X., Seo, J., Petibone, D. M., Tryndyak, V., Lee, U. J., Zhou, T., Robison, T. W., & Mei, N. (2020) · Journal of Toxicology and Environmental Health · doi:10.1080/15287394.2020.1822972 · Cited by 37
Integration of new approach methods for the assessment of data-poor chemicals
Friedman, K. P., Thomas, R. S., Wambaugh, J. F., Harrill, J., Judson, R., Shafer, T. J., Williams, A. J., Lee, J.-Y. J., Loo, L., Gagné, M., et al. (2025) · Toxicological Sciences · doi:10.1093/toxsci/kfaf019 · Cited by 36
Sahu, S. C., Njoroge, J. M., Bryce, S. M., Yourick, J. J., & Sprando, R. L. (2014) · Journal of Applied Toxicology · doi:10.1002/jat.3065 · Cited by 36
Robinson, J. F., Theunissen, P. T., van Dartel, D. A. M., Pennings, J. L. A., Faustman, E. M., & Piersma, A. H. (2011) · Reproductive Toxicology · doi:10.1016/j.reprotox.2011.05.011 · Cited by 36
Tea and coffee consumption in relation to DNA methylation in four European cohorts
Ek, W. E., Tobi, E. W., Ahsan, M., Lampa, E., Ponzi, E., Kyrtopoulos, S. Α., Georgiadis, P., Lumey, L. H., Heijmans, B. T., Botsivali, M., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx194 · Cited by 35
Herzog, N., Katzenberger, N., Martin, F., Schmidtke, K., & Kocks, J. W. H. (2015) · Journal of Cellular Biotechnology · doi:10.3233/jcb-15002 · Cited by 34
Interactions between hepatitis B virus and aflatoxin B1: effects on p53 induction in HepaRG cells
Lereau, M., Gouas, D. A., Villar, S., Nia, A. B., Hautefeuille, A. H., Berthillon, P., Martel-Planche, G., da Costa, A. N., Ortiz‐Cuaran, S., Hantz, O., et al. (2011) · Journal of General Virology · doi:10.1099/vir.0.032482-0 · Cited by 34
Buick, J. K., Williams, A., Gagné, R., Swartz, C. D., Recio, L., Ferguson, S., & Yauk, C. L. (2020) · Genes and Environment · doi:10.1186/s41021-019-0139-2 · Cited by 34
RNA modifications as emerging therapeutic targets
Çayır, A. (2021) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1702 · Cited by 34
Hoekstra, R., Nibourg, G. A. A., van der Hoeven, T. V., Plomer, G., Seppen, J., Ackermans, M. T., Camus, S., Kulik, W., van Gulik, T. M., Elferink, R. P. J. O., et al. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.049098 · Cited by 33
Fatema, K., Shoily, S. S., Ahsan, T., Haidar, Z., Sumit, A. F., & Sajib, A. A. (2021) · Toxicology Reports · doi:10.1016/j.toxrep.2021.05.015 · Cited by 33
Dietary lipids modulate methylmercury toxicity in Atlantic salmon
Olsvik, P. A., Amlund, H., & Torstensen, B. E. (2011) · Food and Chemical Toxicology · doi:10.1016/j.fct.2011.09.025 · Cited by 33
Tryndyak, V., Kindrat, I., Dreval, K., Churchwell, M. I., Beland, F. A., & Pogribny, I. P. (2018) · Food and Chemical Toxicology · doi:10.1016/j.fct.2018.08.034 · Cited by 32
Mundy, L. J., Williams, K. L., Chiu, S., Pauli, B. D., & Crump, D. (2019) · Environmental Science & Technology · doi:10.1021/acs.est.9b02066 · Cited by 35
Solan, M. E., & Lavado, R. (2023) · Current Research in Toxicology · doi:10.1016/j.crtox.2023.100116 · Cited by 33
Baderna, D., Colombo, A., Amodei, G., Cantù, S., Teoldi, F., Cambria, F., Rotella, G., Natolino, F., Lodi, M., & Benfenati, E. (2013) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2013.06.088 · Cited by 32
Sahu, S. C., Njoroge, J. M., Bryce, S. M., Zheng, J., & Ihrie, J. (2016) · Journal of Applied Toxicology · doi:10.1002/jat.3276 · Cited by 32
Pisani, C., Rascol, E., Dorandeu, C., Charnay, C., Guari≠, Y., Chopineau, J., Devoisselle, J., & Prat, O. (2017) · Nanotoxicology · doi:10.1080/17435390.2017.1378749 · Cited by 30
Sahu, S. C., Roy, S. K., Zheng, J., & Ihrie, J. (2016) · Journal of Applied Toxicology · doi:10.1002/jat.3279 · Cited by 29
Jiang, J., Pieterman, C., Ertaylan, G., Peeters, R., & de Kok, T. M. C. M. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02585-5 · Cited by 32
Advanced In Vitro HepaRG Culture Systems for Xenobiotic Metabolism and Toxicity Characterization
Ashraf, M. N., Asghar, M. W., Rong, Y., Doschak, M. R., & Kiang, T. K. L. (2018) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-018-0533-3 · Cited by 29
Li, A., Lü, X., Natoli, T. E., Bittker, J. A., Sipes, N. S., Subramanian, A., Auerbach, S. S., Sherr, D. H., & Monti, S. (2019) · Environmental Health Perspectives · doi:10.1289/ehp3986 · Cited by 28
Matteo, G., Hoyeck, M. P., Blair, H. L., Zebarth, J., Rick, K. R. C., Williams, A., Gagné, R., Buick, J. K., Yauk, C. L., & Bruin, J. E. (2021) · Endocrinology · doi:10.1210/endocr/bqab050 · Cited by 28
Hepatic Transcriptome Responses of Domesticated and Wild Turkey Embryos to Aflatoxin B1
Monson, M. S., Cardona, C. J., Coulombe, R. A., & Reed, K. M. (2016) · Toxins · doi:10.3390/toxins8010016 · Cited by 28
Transcriptomic alterations induced by aflatoxin B1 and ochratoxin A in LMH cell line
Choi, S.-Y., Kim, T. H., Hong, M.-W., Park, T. S., Lee, H., & Lee, S. (2020) · Poultry Science · doi:10.1016/j.psj.2020.05.058 · Cited by 28
C9orf16 (BBLN) gene, encoding a member of Hero proteins, is a novel marker in ischemic stroke risk
Kobzeva, K., Shilenok, I. V., Белых, А. Е., Gurtovoy, D. E., Bobyleva, L. A., Krapiva, A. B., Stetskaya, T. A., Быканова, М. А., Mezhenskaya, A. A., Lysikova, E. A., et al. (2022) · RESEARCH RESULTS IN BIOMEDICINE · doi:10.18413/2658-6533-2022-8-3-0-2 · Cited by 29
Toxicogenomics of drug induced liver injury – from mechanistic understanding to early prediction.
Lauschke, V. M. (2021) · Drug Metabolism Reviews · doi:10.1080/03602532.2021.1894571 · Cited by 29
Kobzeva, K., Soldatova, M. O., Stetskaya, T. A., Soldatov, V. O., Deykin, A. V., Freidin, M. B., Быканова, М. А., Churnosov, M. I., Polonikov, A., & Bushueva, O. Y. (2023) · Genes · doi:10.3390/genes14061171 · Cited by 29
Ajiboye, T. O., Yakubu, M. T., & Oladiji, A. T. (2016) · Pharmaceutical Biology · doi:10.3109/13880209.2015.1137603 · Cited by 26
Lu, J., Zhang, Y., Sun, M., Liu, M., & Wang, X. (2017) · Phytomedicine · doi:10.1016/j.phymed.2017.01.004 · Cited by 25
Opportunities for an alternative integrating testing strategy for carcinogen hazard assessment?
Doktorova, T. Y., Pauwels, M., Vinken, M., Vanhaecke, T., & Rogiers, V. (2011) · Critical Reviews in Toxicology · doi:10.3109/10408444.2011.623151 · Cited by 25
Interactive toxicity of usnic acid and lipopolysaccharides in human liver HepG2 cells
Sahu, S. C., O'Donnell, M. W., & Sprando, R. L. (2012) · Journal of Applied Toxicology · doi:10.1002/jat.2768 · Cited by 24
Reprogramming of the HepG2 genome by long interspersed nuclear element‐1
Bojang, P., Roberts, R. A., Anderton, M. J., & Ramos, K. S. (2013) · Molecular Oncology · doi:10.1016/j.molonc.2013.04.003 · Cited by 24
Rieswijk, L., Brauers, K. J. J., Coonen, M. L. J., Breda, S. G. J. V., Jennen, D. G. J., & Kleinjans, J. C. S. (2015) · Mutagenesis · doi:10.1093/mutage/gev036 · Cited by 23
Self-citationJetten, M. J. A., Claessen, S. M. H., Dejong, C. H. C., Lahoz, A., Castell, J. V., van Delft, J. H. M., & Kleinjans, J. C. S. (2014) · Toxicology · doi:10.1016/j.tox.2014.06.007 · Cited by 23
Self-citationKienhuis, A. S., Vitins, A. P., Pennings, J. L. A., Pronk, T. E., Speksnijder, E. N., Roodbergen, M., van Delft, J. H. M., Luijten, M., & van der Ven, L. T. M. (2013) · Toxicology Letters · doi:10.1016/j.toxlet.2013.06.236 · Cited by 22
Mycotoxins as Food Carcinogens
Vettorazzi, A., & de Ceráin, A. L. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-411471-5.00017-x · Cited by 20
Metadata
- Authors
- Jennen, D. G. J., Magkoufopoulou, C., Ketelslegers, H. B., van Herwijnen, M. H. M., Kleinjans, J. C. S., & van Delft, J. H. M.
- Affiliations
- Maastricht University (NL)
- Corresponding author
- Jennen, Danyel G. J.
- Venue
- Toxicological Sciences
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-01-27
- Volume
- 115
- Issue
- 1
- Pages
- 66-79
- ISSN
- 1096-0929 (ISSN-L)
- 1096-6080
- OpenAlex
- W2169675397
- Cited by
- 220
- References
- 42
- Citations by year
- 2026: 6 · 2025: 10 · 2024: 15 · 2023: 10 · 2022: 8 · 2021: 8 · 2020: 14 · 2019: 14 · 2018: 14 · 2017: 7 · 2016: 24 · 2015: 14 · 2014: 19 · 2013: 16 · 2012: 21
- FWCI
- 5.74
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Toxicological Sciences (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Funders
- European Commission (LSHB-CT-2006-037712)
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- Stichting voor de Technische Wetenschappen (MFA6809)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Carcinogens and Genotoxicity Assessment
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Keywords
- HepG2 cells, HepaRG cells, hepatoma cell lines, in vitro liver models, carcinogenicity classification, genotoxic carcinogens, non-genotoxic carcinogens, aflatoxin B1, benzo[a]pyrene, cyclosporine, estradiol, 2,3,7,8-tetrachlorodibenzo-p-dioxin, whole-genome gene expression, toxicogenomics, primary human hepatocytes, cell cycle regulation, apoptosis, chemical hazard identification
- MeSH terms
- Carcinogens, Humans, Predictive Value of Tests, Carcinogenicity Tests, Gene Expression Regulation, Neoplastic, Risk Assessment, Gene Expression Profiling, Hepatocytes, Genomics, Animal Use Alternatives, Hep G2 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review